Rachel Riechelmann
Overview
Explore the profile of Rachel Riechelmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morris V, Kennedy E, Amin M, Aranha O, Benson 3rd A, Dorth J, et al.
J Clin Oncol
. 2024 Dec;
43(5):605-615.
PMID: 39680825
Purpose: To provide evidence-based guidance for clinicians who treat patients with stage I-III anal cancer. Methods: A systematic review of the literature conducted by the Minnesota Evidence-based Practice Center provided...
2.
Saldanha E, Powis M, Sharma D, Espin-Garcia O, Hack S, Cavalher F, et al.
JCO Glob Oncol
. 2024 Sep;
10:e2400037.
PMID: 39348613
Purpose: The early phase of the COVID-19 pandemic affected cancer care globally. Evaluating the impact of the pandemic on the quality of cancer care delivery is crucial for understanding how...
3.
Peixoto R, Coutinho A, Prolla G, Weschenfelder R, Riechelmann R
Ecancermedicalscience
. 2023 Jun;
17:1544.
PMID: 37377686
Recent advances in biomarker-driven therapies have changed the landscape of unresectable metastatic colorectal cancer (mCRC) and brought not only access issues but also difficulties for the treating physician (especially generalist...
4.
Farrokhi P, Sadeghi A, Sharifi M, Riechelmann R, Moghaddas A
Res Pharm Sci
. 2023 Jan;
17(6):621-634.
PMID: 36704436
Background And Purpose: This study aimed to compare the efficacy and toxicity of perioperative chemotherapy regimens including epirubicin, cisplatin, 5-fluorouracil (ECF), docetaxel, cisplatin, 5-fluorouracil (DCF), leucovorin, 5-fluorouracil, oxaliplatin (FOLFOX), and...
5.
Grozinsky-Glasberg S, Davar J, Hofland J, Dobson R, Prasad V, Pascher A, et al.
J Neuroendocrinol
. 2022 May;
34(7):e13146.
PMID: 35613326
No abstract available.
6.
Franco P, Segelov E, Johnsson A, Riechelmann R, Guren M, Das P, et al.
Cancers (Basel)
. 2022 Apr;
14(7).
PMID: 35406469
Squamous-cell carcinoma of the anus (ASCC) is a rare disease. Barriers have been encountered to conduct clinical and translational research in this setting. Despite this, ASCC has been a prime...
7.
Hofland J, Lamarca A, Steeds R, Toumpanakis C, Srirajaskanthan R, Riechelmann R, et al.
J Neuroendocrinol
. 2021 Nov;
34(3):e13060.
PMID: 34825753
Background: This European Neuroendocrine Tumor Society (ENETS) Expert Consensus document aims to provide practical guidance and standardization for echocardiography in the screening and follow-up of carcinoid heart disease (CHD) in...
8.
Lara Gongora A, Werutsky G, Jardim D, Nogueira-Rodrigues A, Barrios C, Mathias C, et al.
JCO Glob Oncol
. 2021 May;
7:649-658.
PMID: 33956499
Purpose: COVID-19 has affected cancer care worldwide. Clinical trials are an important alternative for the treatment of oncologic patients, especially in Latin America, where trials can be the only opportunity...
9.
Rocha-Filho D, Peixoto R, Weschenfelder R, Rego J, Riechelmann R, Coutinho A, et al.
Ecancermedicalscience
. 2021 Apr;
15:1195.
PMID: 33889204
Oesophageal cancer is among the ten most common types of cancer worldwide. More than 80% of the cases and deaths related to the disease occur in developing countries. Local socio-economic,...
10.
E Silva V, Abdallah E, de Brito A, Braun A, Tariki M, de Mello C, et al.
Diagnostics (Basel)
. 2021 Apr;
11(3).
PMID: 33809053
The discovery of predictive biomarkers in metastatic colorectal cancer (mCRC) is essential to improve clinical outcomes. Recent data suggest a potential role of circulating tumor cells (CTCs) as prognostic indicators....